DE69430990D1 - Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut - Google Patents

Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut

Info

Publication number
DE69430990D1
DE69430990D1 DE69430990T DE69430990T DE69430990D1 DE 69430990 D1 DE69430990 D1 DE 69430990D1 DE 69430990 T DE69430990 T DE 69430990T DE 69430990 T DE69430990 T DE 69430990T DE 69430990 D1 DE69430990 D1 DE 69430990D1
Authority
DE
Germany
Prior art keywords
composition
human whole
blood cells
whole blood
white blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69430990T
Other languages
English (en)
Other versions
DE69430990T2 (de
Inventor
Lawrence Kass
Leonard Spolter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iris International Inc
Original Assignee
International Remote Imaging Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Remote Imaging Systems Inc filed Critical International Remote Imaging Systems Inc
Application granted granted Critical
Publication of DE69430990D1 publication Critical patent/DE69430990D1/de
Publication of DE69430990T2 publication Critical patent/DE69430990T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
DE69430990T 1993-04-26 1994-04-14 Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut Expired - Lifetime DE69430990T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/052,504 US5397479A (en) 1993-04-26 1993-04-26 Composition and method for enrichment of white blood cells from whole human blood
PCT/US1994/004186 WO1994025135A1 (en) 1993-04-26 1994-04-14 Composition and method for enrichment of white blood cells from whole human blood

Publications (2)

Publication Number Publication Date
DE69430990D1 true DE69430990D1 (de) 2002-08-22
DE69430990T2 DE69430990T2 (de) 2003-07-31

Family

ID=21978046

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69430990T Expired - Lifetime DE69430990T2 (de) 1993-04-26 1994-04-14 Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut

Country Status (7)

Country Link
US (2) US5397479A (de)
EP (1) EP0696933B1 (de)
JP (1) JPH08510322A (de)
AU (1) AU686158B2 (de)
CA (1) CA2161408A1 (de)
DE (1) DE69430990T2 (de)
WO (1) WO1994025135A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789148A (en) * 1994-08-31 1998-08-04 Dendreon Corporation Cell separation composition
US7169547B2 (en) * 1994-12-05 2007-01-30 New York Blood Center, Inc. High concentration white blood cells as a therapeutic product
US5789147A (en) * 1994-12-05 1998-08-04 New York Blood Center, Inc. Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US5725774A (en) * 1995-04-07 1998-03-10 Lxn Corp. Whole blood separation method and devices using the same
US5674173A (en) * 1995-04-18 1997-10-07 Cobe Laboratories, Inc. Apparatus for separating particles
US5939319A (en) * 1995-04-18 1999-08-17 Cobe Laboratories, Inc. Particle separation method and apparatus
US5913768A (en) * 1995-04-18 1999-06-22 Cobe Laboratories, Inc. Particle filter apparatus
US6053856A (en) * 1995-04-18 2000-04-25 Cobe Laboratories Tubing set apparatus and method for separation of fluid components
US6022306A (en) * 1995-04-18 2000-02-08 Cobe Laboratories, Inc. Method and apparatus for collecting hyperconcentrated platelets
JPH11505327A (ja) 1995-05-09 1999-05-18 スミスクライン ダイアグノスティックス インコーポレイテッド 血液の液体部分から血液の細胞成分を分離する装置および方法
US5888822A (en) 1995-10-04 1999-03-30 Hycor Biomedical Inc. Erythrocyte sedimentation rate control
JP4719326B2 (ja) * 1996-08-15 2011-07-06 司 松元 赤血球の分画法
AU4101697A (en) * 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
US5879951A (en) 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US5895760A (en) * 1997-02-04 1999-04-20 Hycor Biomedical, Inc. Erythrocyte sedimentation rate control
US5939252A (en) 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device
US6051146A (en) * 1998-01-20 2000-04-18 Cobe Laboratories, Inc. Methods for separation of particles
US6723290B1 (en) 1998-03-07 2004-04-20 Levine Robert A Container for holding biologic fluid for analysis
US5948686A (en) * 1998-03-07 1999-09-07 Robert A. Leuine Method for performing blood cell counts
US6929953B1 (en) 1998-03-07 2005-08-16 Robert A. Levine Apparatus for analyzing biologic fluids
US6535393B2 (en) * 1998-12-04 2003-03-18 Micron Technology, Inc. Electrical device allowing for increased device densities
US6153113A (en) 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
US6334842B1 (en) 1999-03-16 2002-01-01 Gambro, Inc. Centrifugal separation apparatus and method for separating fluid components
US6159682A (en) * 1999-04-30 2000-12-12 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
US6124089A (en) 1999-04-30 2000-09-26 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
US7135335B2 (en) * 1999-05-28 2006-11-14 Stemcell Technologies Inc. Method for separating cells using immunorosettes
US6354986B1 (en) 2000-02-16 2002-03-12 Gambro, Inc. Reverse-flow chamber purging during centrifugal separation
US6531321B1 (en) 2000-09-15 2003-03-11 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
EP1916297B1 (de) * 2001-04-10 2010-12-29 BioE LLC Zelltrennungszusammensetzungen und -verfahren
US7316932B2 (en) * 2001-10-01 2008-01-08 Stemcell Technologies Inc. Method for separating cells
US8986944B2 (en) * 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US8980568B2 (en) * 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
WO2003031938A2 (en) 2001-10-11 2003-04-17 Aviva Biosciences Corporation Methods, compositions, and automated systems for separating rare cells from fluid samples
US7166443B2 (en) 2001-10-11 2007-01-23 Aviva Biosciences Corporation Methods, compositions, and automated systems for separating rare cells from fluid samples
EP1547606A4 (de) * 2002-08-02 2006-07-12 Emi Sumida Verfahren zur herstellung von thrombozytenreichem plasma
WO2005072753A1 (ja) * 2004-01-30 2005-08-11 Toray Industries, Inc. 多血小板血漿からなる組成物
ATE490462T1 (de) * 2005-04-08 2010-12-15 Medical Discovery Partners Llc Verfahren zum anreichern von subpopulationen seltener zellen aus dem blut
WO2008008515A2 (en) * 2006-07-14 2008-01-17 Aviva Biosciences Corporation Methods and compositions for detecting rare cells from a biological sample
US8304185B2 (en) 2009-07-17 2012-11-06 Canon U.S. Life Sciences, Inc. Methods and systems for DNA isolation on a microfluidic device
US8313906B2 (en) * 2008-07-18 2012-11-20 Canon U.S. Life Sciences, Inc. Methods and systems for microfluidic DNA sample preparation
US8961787B2 (en) * 2008-12-01 2015-02-24 General Electric Company Systems and methods for processing complex biological materials
US20100151438A1 (en) * 2008-12-12 2010-06-17 General Electric Company Methods and kits for enhancing sedimentation and recovery of cells in a sample
KR101720808B1 (ko) * 2008-12-01 2017-03-28 제너럴 일렉트릭 캄파니 세포를 체액으로부터 분리하기 위한 시스템 및 방법
US8177072B2 (en) * 2008-12-04 2012-05-15 Thermogenesis Corp. Apparatus and method for separating and isolating components of a biological fluid
AU2010330825B2 (en) * 2009-12-18 2014-03-06 Abbott Point Of Care, Inc. Biologic fluid analysis cartridge
US9199233B2 (en) 2010-03-31 2015-12-01 Abbott Point Of Care, Inc. Biologic fluid analysis cartridge with deflecting top panel
CA2819260A1 (en) 2010-12-15 2012-06-21 Cytosed, Inc. Antibody-linked immuno-sedimentation agent and method of isolating a target from a sample using same
US9873118B2 (en) 2010-12-30 2018-01-23 Abbott Point Of Care, Inc. Biologic fluid analysis cartridge with sample handling portion and analysis chamber portion
CN105817276B (zh) 2011-08-24 2018-02-06 艾博特健康公司 生物流体样品分析盒
US10088469B2 (en) 2012-08-30 2018-10-02 Qiagen Gmbh Method for obtaining blood plasma from a whole blood sample
WO2014127122A1 (en) 2013-02-18 2014-08-21 Terumo Bct, Inc. System for blood separation with a separation chamber having an internal gravity valve
GB201306810D0 (en) * 2013-04-15 2013-05-29 Cells4Life Group Llp Methods of cell separation
MX2017008823A (es) * 2014-12-31 2017-11-17 Anthrogenesis Corp Metodos para aislamiento de plaquetas.
KR102589056B1 (ko) * 2015-12-08 2023-10-12 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
JP6836700B2 (ja) * 2017-07-13 2021-03-03 稲田　捷也 敗血症患者血中エンドトキシン測定のための試料調整方法
JP2020115787A (ja) * 2019-01-24 2020-08-06 住友ゴム工業株式会社 細胞培養装置及び細胞培養方法
CA3170079A1 (en) * 2020-03-11 2021-09-16 Kuniya KOMAI Leukocyte concentration separation device, blood collection container, and method for separating leukocytes
GB2616667A (en) * 2022-03-18 2023-09-20 Entia Ltd A composition for coating a cuvette and a method of making a composition for coating a cuvette

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704096A1 (de) * 1977-02-01 1978-08-03 Bissbort Siegbert Dipl Biologe Verfahren zur elektrophoretischen untersuchung von proteinen
US4181609A (en) * 1977-12-20 1980-01-01 Levine Robert A Blood constituents testing method
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
US4255256A (en) * 1978-12-13 1981-03-10 Antonio Ferrante Medium for the separation of human blood leucocytes
US4765899A (en) * 1983-10-11 1988-08-23 E. I. Du Pont De Nemours And Company Apparatus for continuous separation of leukocyte/platelet-enriched fraction from whole blood
US4663058A (en) * 1983-10-11 1987-05-05 E. I. Du Pont De Nemours And Company Process for continuous separation of leukocyte/platelet-enriched fraction from whole blood
US4968432A (en) * 1988-05-18 1990-11-06 Cobe Laboratories, Inc. Treatment of liquid including blood components
US5118428A (en) * 1990-11-13 1992-06-02 Quidel Method to remove red blood cells from whole blood samples
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液

Also Published As

Publication number Publication date
EP0696933A1 (de) 1996-02-21
DE69430990T2 (de) 2003-07-31
WO1994025135A1 (en) 1994-11-10
EP0696933B1 (de) 2002-07-17
US5482829A (en) 1996-01-09
JPH08510322A (ja) 1996-10-29
EP0696933A4 (de) 1997-09-24
US5397479A (en) 1995-03-14
CA2161408A1 (en) 1994-11-10
AU6635894A (en) 1994-11-21
AU686158B2 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
DE69430990T2 (de) Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE3586159D1 (de) Zusammensetzung und verfahren zur differenzierung von weissen blutzellen.
DE68919304D1 (de) Leitfähige Zusammensetzung und Methode zur Herstellung derselben.
DE69431714T2 (de) Verfahren und zusammensetzung zur verdauung von gewebe
DE69422669D1 (de) Vorrichtung und Methode zur optischen Bestimmung von Konzentrationen
DE69424522T2 (de) Methode zur resuspendierung von zellreichen konzentraten
DE68903884T2 (de) Mittel und methode zur bestimmung von spurenmengen an proteinen.
DE3860919D1 (de) Verbesserte detergens-bleichmittelzusammensetzung und verfahren zur reinigung von geweben.
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
DE69121411D1 (de) Methode und gerät zur codierung von analogen signalen
DE69314639D1 (de) Methode und vorrichtung zur herstellung von brennstoffen
DE69510174D1 (de) Verfahren und Reagenz zur Bestimmung von menschlichen Störungen
DE59403959D1 (de) Verfahren zur Herstellung von Diurethanen und ihrer Verwendung zur Herstellung von Diisocyanaten
DE3669507D1 (de) 1-benzyl-2-(n-substituierte)-carbamoyltetrahydroisochinoline und methode zur ihrer herstellung.
DE69128781T2 (de) Zusammensetzung und methode zur immunstimulierung in säugetieren
DE69424690T2 (de) Methode zur herstellung von kollagen aus cnidarians und entsprechende kosmetische zusammensetzungen
DE69020188D1 (de) Sterilisiermischung und Verfahren zur Sterilisierung.
DE69625883D1 (de) Zusammensetzung zur Reinigung und/oder Desinfektion von medizinischen Geräten
DE68925918T2 (de) Methode zur Reinigung von Antithrombin-III und Antithrombin-III-Zusammensetzung enthaltend dieses Antithrombin-III
DE69418931T2 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
DE3674585D1 (de) Zubereitung zur behandlung und vorbeugung von diarrhoee bei menschen und tieren und verfahren zu deren herstellung.
DE69517055D1 (de) Methode zur abtrennung von pentafluoroethan und verfahren zur herstellung von pentafluoroethan durch gebrauch dieser methode
PT86606A (pt) Bakterienlysierendes enzymprodukt aus streptomyceten seine herstellung und seine verwendung zur konservierung von kaese
DE9218381U1 (de) Implantat zur Stabilisierung von Wirbeln

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition